Unity Biotechnology (STU:9U90) Short-Term Capital Lease Obligation : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Short-Term Capital Lease Obligation?

Unity Biotechnology's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.00 Mil.

Unity Biotechnology's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€3.17 Mil) but then declined from Dec. 2023 (€3.17 Mil) to Mar. 2024 (€0.00 Mil).

Unity Biotechnology's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (€3.88 Mil) to Dec. 2022 (€2.93 Mil) but then increased from Dec. 2022 (€2.93 Mil) to Dec. 2023 (€3.17 Mil).

Unity Biotechnology Short-Term Capital Lease Obligation Historical Data

The historical data trend for Unity Biotechnology's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Short-Term Capital Lease Obligation Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

3.72

3.88

2.93

3.17

Unity Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	3.17	-

Unity Biotechnology Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Unity Biotechnology Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines